Logo CONMED Corporation

CONMED Corporation (CNMD) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
CONMED Corporation · Health Care · ref. ETF XLV · 56 calls · price $50.32
🏆JPI 2026 portfoliosSee tracking →
What the company does: CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.

📈 CONMED Corporation (CNMD) stock price

$50.32-6.3% over range
Aug 28, 25low $32.11 · high $54.97Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 5 analysts
📊 JPI status : CONMED Corporation has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 CNMD price target & analyst consensusprice $50.32

The price target · all analysts combined (5 targets)
Highest target · 1 firm of 5$46-8.6%
Median target · of 5 targets$40-20.5%
Lowest target · 1 firm of 5$36-28.5%
Current price$50.32
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Below 5100% $36 ↔ $46
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 5 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold480%
Sell120%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about CONMED Corporation? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

🏛️ Which US Congress members hold CONMED Corporation (CNMD)?

1 Congress member has disclosed CNMD buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Nicholas Taylor
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on CNMD

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Ladenburg Thalmann  50% +3.0% 2
Stifel  30% +0.9% 10
Needham  22% -20.8% 23
JP Morgan  20% +2.4% 5
Piper Sandler  18% -8.5% 11
Barclays  0% -16.4% 2
Leerink Swann 0% -22.2% 2
Keybanc  0% -37.4% 3

📊 What $1,000 invested in CONMED Corporation would be worth › open the full page

In short — $1,000 invested in CONMED Corporation 10 years ago would be worth $948 today, i.e. -1%/yr on average. Best year: 2019 (+74%), worst: 2025 (-41%). Price performance, excluding dividends.

If I'd invested $1,000 in CONMED Corporation

InvestmentWorth todayGain
1 years ago$610-39%
3 years ago$471-53%
5 years ago$373-63%
→ See CONMED Corporation's full return history + gain calculator

Return by year (CONMED Corporation)

YearReturn$1,000 invested at year start
2026 (YTD)+3%$1,028 (+3%)
2025-41%$610 (-39%)
2024-38%$381 (-62%)
→ See CONMED Corporation's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on CONMED Corporation

Loading news…

📋 All analyst calls on CNMD

Piper Sandler 
Jul 30, 26
■ Neutral neutral · not a buy · 🎯$45
Price at call : $46.3 — gap to target -3%
Today : $50.32 — gap to target -11%
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Jul 30, 27
Wells Fargo 
Jul 30, 26
■ Equal-Weight neutral · not a buy · 🎯$46
Price at call : $46.3 — gap to target -1%
Today : $50.32 — gap to target -9%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jul 30, 27
BMO Capital 
Jul 9, 26
■ Market Perform neutral · not a buy · 🎯$36
Price at call : $38.48 — gap to target -6%
Today : $50.32 — gap to target -28%
🎯 on CNMD : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Jul 9, 27
▼ Underperform · 🎯$40
Price at call : $34.41 — upside +16%
Today : $50.32 — upside -21%
🎯 on CNMD : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Jun 29, 27
■ Neutral neutral · not a buy · 🎯$40
Price at call : $36.18 — gap to target +11%
Today : $50.32 — gap to target -21%
🎯 on CNMD : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : May 18, 27
Wells Fargo 
May 1, 26
■ Equal-Weight neutral · not a buy · 🎯$39
Price at call : $35.88 — gap to target +9%
Today : $50.32 — gap to target -22%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 1, 27
JP Morgan 
May 1, 26
■ Neutral neutral · not a buy · 🎯$40
Price at call : $36.8 — gap to target +9%
Today : $50.32 — gap to target -21%
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : May 1, 27
Piper Sandler 
Mar 17, 26
■ Neutral neutral · not a buy · 🎯$39
Price at call : $37.34 — gap to target +4%
Today : $50.32 — gap to target -22%
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Mar 17, 27
See the other 48 calls, newest to oldest
Wells Fargo 
Jan 29, 26
■ Equal-Weight neutral · not a buy · 🎯$42
Price at call : $37.31 — gap to target +13%
Today : $50.32 — gap to target -17%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jan 29, 27
Needham 
Jan 29, 26
■ Hold neutral · not a buy
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jan 29, 27
■ Neutral neutral · not a buy · 🎯$52
Price at call : $40.57 — gap to target +28%
Today : $50.32 — gap to target +3%
🎯 on CNMD : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Dec 8, 26
JP Morgan 
Nov 6, 25
■ Neutral neutral · not a buy · 🎯$52
Price at call : $43.97 — gap to target +18%
Today : $50.32 — gap to target +3%
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Nov 6, 26
Piper Sandler 
Nov 6, 25
▲ Overweight · 🎯$55
Price at call : $43.97 — upside +25%
Today : $50.32 — upside +9%
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Nov 6, 26
Wells Fargo 
Nov 6, 25
■ Equal-Weight neutral · not a buy · 🎯$47
Price at call : $43.97 — gap to target +7%
Today : $50.32 — gap to target -7%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Nov 6, 26
Piper Sandler 
Jul 31, 25
▲ Overweight · 🎯$68
Price at call : $52.29 — upside +30%
Today : $50.32 — upside +35%
Expected +30% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-0.8%
stock -1% · XLV +24%
matured Jul 31, 26
Needham 
Jun 12, 25
■ Hold neutral · not a buy · 🎯$61
Price at call : $54.97 — gap to target +11%
Today : $50.32 — gap to target +21%
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jun 12, 26
JP Morgan 
May 1, 25
■ Neutral neutral · not a buy · 🎯$58
Price at call : $57.68 — gap to target +1%
Today : $50.32 — gap to target +15%
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : May 1, 26
Wells Fargo 
May 1, 25
■ Equal-Weight neutral · not a buy · 🎯$57
Price at call : $57.68 — gap to target -1%
Today : $50.32 — gap to target +13%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 1, 26
Needham 
May 1, 25
▲ Buy · 🎯$61
Price at call : $57.19 — upside +7%
Today : $50.32 — upside +21%
Expected +7% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-35.6%
stock -36% · XLV +6%
matured May 1, 26
Stifel 
Apr 28, 25
■ Hold neutral · not a buy · 🎯$55
Price at call : $51.17 — gap to target +7%
Today : $50.32 — gap to target +9%
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Apr 28, 26
Stifel 
Feb 6, 25
▲ Buy · 🎯$75
Price at call : $66.43 — upside +13%
Today : $50.32 — upside +49%
Expected +13% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
-37.3%
stock -37% · XLV +7%
matured Feb 6, 26
Wells Fargo 
Feb 6, 25
■ Equal-Weight neutral · not a buy · 🎯$70
Price at call : $66.43 — gap to target +5%
Today : $50.32 — gap to target +39%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 6, 26
Needham 
Feb 6, 25
▲ Buy · 🎯$91
Price at call : $67.36 — upside +35%
Today : $50.32 — upside +81%
Expected +35% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-38.4%
stock -38% · XLV +7%
matured Feb 6, 26
JP Morgan 
Feb 6, 25
■ Neutral neutral · not a buy · 🎯$70
Price at call : $67.36 — gap to target +4%
Today : $50.32 — gap to target +39%
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Feb 6, 26
Needham 
Oct 31, 24
▲ Buy · 🎯$97
Price at call : $68.24 — upside +42%
Today : $50.32 — upside +93%
Expected +42% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-35.5%
stock -36% · XLV -2%
matured Oct 31, 25
Needham 
Oct 4, 24
▲ Buy · 🎯$97
Price at call : $64.05 — upside +51%
Today : $50.32 — upside +93%
Expected +51% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-27.5%
stock -27% · XLV -5%
matured Oct 4, 25
Piper Sandler 
Aug 1, 24
▲ Overweight · 🎯$80
Price at call : $68.67 — upside +16%
Today : $50.32 — upside +59%
Expected +16% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-22.1%
stock -22% · XLV -12%
matured Aug 1, 25
Stifel 
Aug 1, 24
▲ Buy · 🎯$76
Price at call : $68.67 — upside +11%
Today : $50.32 — upside +51%
Expected +11% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
-22.1%
stock -22% · XLV -12%
matured Aug 1, 25
Wells Fargo 
Aug 1, 24
■ Equal-Weight neutral · not a buy · 🎯$71
Price at call : $68.67 — gap to target +3%
Today : $50.32 — gap to target +41%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 1, 25
Needham 
Aug 1, 24
▲ Buy · 🎯$97
Price at call : $65.34 — upside +48%
Today : $50.32 — upside +93%
Expected +48% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-20.0%
stock -20% · XLV -13%
matured Aug 1, 25
Needham 
Jul 25, 24
▲ Buy · 🎯$106
Price at call : $70.6 — upside +50%
Today : $50.32 — upside +111%
Expected +50% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-27.8%
stock -28% · XLV -8%
matured Jul 25, 25
Needham 
May 6, 24
▲ Buy · 🎯$107
Price at call : $70.75 — upside +51%
Today : $50.32 — upside +113%
Expected +51% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-21.0%
stock -21% · XLV -5%
matured May 6, 25
JP Morgan 
Apr 25, 24
▲ Overweight · 🎯$75
Price at call : $65.78 — upside +14%
Today : $50.32 — upside +49%
Expected +14% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-22.7%
stock -23% · XLV -1%
matured Apr 25, 25
Wells Fargo 
Apr 25, 24
■ Equal-Weight neutral · not a buy · 🎯$77
Price at call : $65.78 — gap to target +17%
Today : $50.32 — gap to target +53%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Apr 25, 25
Piper Sandler 
Apr 25, 24
▲ Overweight · 🎯$95
Price at call : $61.9 — upside +53%
Today : $50.32 — upside +89%
Expected +53% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-18.1%
stock -18% · XLV -1%
matured Apr 25, 25
Needham 
Apr 25, 24
▲ Buy · 🎯$107
Price at call : $61.9 — upside +73%
Today : $50.32 — upside +113%
Expected +73% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-18.1%
stock -18% · XLV -1%
matured Apr 25, 25
Piper Sandler 
Feb 1, 24
▲ Overweight · 🎯$100
Price at call : $80.91 — upside +24%
Today : $50.32 — upside +99%
Expected +24% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-12.0%
stock -12% · XLV +4%
matured Jan 31, 25
JP Morgan 
Feb 1, 24
▲ Overweight · 🎯$115
Price at call : $80.91 — upside +42%
Today : $50.32 — upside +129%
Expected +42% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-12.0%
stock -12% · XLV +4%
matured Jan 31, 25
Wells Fargo 
Feb 1, 24
■ Equal-Weight neutral · not a buy · 🎯$98
Price at call : $83.76 — gap to target +17%
Today : $50.32 — gap to target +95%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jan 31, 25
Needham 
Feb 1, 24
▲ Buy · 🎯$129
Price at call : $83.76 — upside +54%
Today : $50.32 — upside +156%
Expected +54% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-14.3%
stock -14% · XLV +3%
matured Jan 31, 25
Piper Sandler 
Oct 27, 23
▲ Overweight · 🎯$130
Price at call : $97.57 — upside +33%
Today : $50.32 — upside +158%
Expected +33% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-34.6%
stock -35% · XLV +20%
matured Oct 26, 24
Stifel 
Oct 26, 23
▲ Buy · 🎯$120
Price at call : $94.96 — upside +26%
Today : $50.32 — upside +138%
Expected +26% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
-32.9%
stock -33% · XLV +21%
matured Oct 25, 24
Wells Fargo 
Oct 26, 23
■ Equal-Weight neutral · not a buy · 🎯$107
Price at call : $94.38 — gap to target +13%
Today : $50.32 — gap to target +113%
🎯 on CNMD : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Oct 25, 24
Needham 
Oct 26, 23
▲ Buy · 🎯$119
Price at call : $94.38 — upside +26%
Today : $50.32 — upside +136%
Expected +26% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-34.2%
stock -34% · XLV +19%
matured Oct 25, 24
JP Morgan 
Jul 27, 23
▲ Overweight · 🎯$145
Price at call : $118.75 — upside +22%
Today : $50.32 — upside +188%
Expected +22% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (3 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-41.0%
stock -41% · XLV +11%
matured Jul 26, 24
Needham 
Jul 27, 23
▲ Buy · 🎯$140
Price at call : $118.22 — upside +18%
Today : $50.32 — upside +178%
Expected +18% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-39.9%
stock -40% · XLV +11%
matured Jul 26, 24
Keybanc 
Jul 27, 23
▲ Overweight · 🎯$141
Price at call : $118.22 — upside +19%
Today : $50.32 — upside +180%
Expected +19% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
-39.9%
stock -40% · XLV +11%
matured Jul 26, 24
Needham 
Jul 24, 23
▲ Buy · 🎯$139
Price at call : $121.6 — upside +14%
Today : $50.32 — upside +176%
Expected +14% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-39.8%
stock -40% · XLV +9%
matured Jul 23, 24
Needham 
Jun 5, 23
▲ Buy · 🎯$139
Price at call : $125.62 — upside +11%
Today : $50.32 — upside +176%
Expected +11% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (13 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-38.2%
stock -38% · XLV +11%
matured Jun 4, 24
CL King
May 22, 23
▲ Buy · 🎯$140
Price at call : $120.5 — upside +16%
Today : $50.32 — upside +178%
Expected +16% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 0% (1 call matured) · 📊 unranked overall
-37.9%
stock -38% · XLV +11%
matured May 21, 24
Piper Sandler 
Apr 27, 23
▲ Overweight · 🎯$128
Price at call : $125.57 — upside +2%
Today : $50.32 — upside +154%
Expected +2% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-46.5%
stock -46% · XLV +5%
matured Apr 26, 24
Piper Sandler 
Feb 3, 23
▲ Overweight · 🎯$118
Price at call : $102.61 — upside +15%
Today : $50.32 — upside +134%
Expected +15% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-19.6%
stock -20% · XLV +7%
matured Feb 3, 24
Piper Sandler 
Jul 28, 22
▲ Overweight · 🎯$118
Price at call : $99.62 — upside +18%
Today : $50.32 — upside +134%
Expected +18% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+19.2%
stock +19% · XLV +2%
matured Jul 28, 23
Piper Sandler 
Apr 29, 21
▲ Overweight · 🎯$160
Price at call : $140.95 — upside +14%
Today : $50.32 — upside +218%
Expected +14% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-4.9%
stock -5% · XLV +7%
matured Apr 29, 22
Piper Sandler 
Jul 30, 20
▲ Overweight · 🎯$95
Price at call : $82.54 — upside +15%
Today : $50.32 — upside +89%
Expected +15% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+64.8%
stock +65% · XLV +25%
matured Jul 30, 21
Piper Sandler 
Aug 22, 19
▲ Overweight · 🎯$110
Price at call : $100.96 — upside +9%
Today : $50.32 — upside +119%
Expected +9% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on CNMD : 18% (11 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-18.9%
stock -19% · XLV +18%
matured Aug 21, 20

Frequently asked questions

Should I buy CONMED Corporation stock?

This isn't buy advice. For CONMED Corporation, the analyst consensus is "Hold", with an average price target of $40.00 (-21% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 50% of the time (2 calls tracked on CONMED Corporation). We show the numbers — you decide.

Is it too late to buy CONMED Corporation? How high can it go?

The most bullish analyst target on CONMED Corporation is $46.00 (-9% above today's price); the average is $40.00. That's the upside they see. Check how reliable those analysts have actually been on CONMED Corporation on our site before trusting it.

Is CONMED Corporation still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 8 analysts have a real record on CONMED Corporation, the best hitting 50% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in CONMED Corporation? The case for and against

The arguments for and against, one by one, from the numbers: why invest in CNMD (and why hesitate).

What has CONMED Corporation's past performance been?

Historical returns and a "how much if I had invested" calculator: CNMD performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)